Literature DB >> 16585545

Antigen challenge inhibits thymic emigration.

Adam P Uldrich1, Stuart P Berzins, Mark A Malin, Philippe Bouillet, Andreas Strasser, Mark J Smyth, Richard L Boyd, Dale I Godfrey.   

Abstract

T cell development in the thymus involves a series of TCR-mediated control points including TCR-beta selection and positive and negative selection. Approximately half of the thymic sojourn is spent in the medulla, where thymocytes undergo final maturation before emigrating to the periphery. Although it is acknowledged that thymic emigration is an active process, relatively little is known about how this is regulated, why it takes so long, and whether TCR-mediated signaling can influence this step. Using wild-type and TCR transgenic mice, we found that Ag injected i.v. or intrathymically led to a striking reduction in the number of recent thymic emigrants (RTE) in the periphery. This was caused by inhibition of T cell export rather than peripheral deletion, because a cohort of RTE that was already released before in vivo Ag challenge was not depleted, and similar results were observed in Bim-deficient mice, which have impaired T cell deletion. Within the thymus, the loss of RTE was associated with retention of medullary thymocytes rather than increased negative selection. In addition to Ag-specific inhibition of export, some TCR-independent suppression of emigration was also observed that appeared to be partly the result of the inflammatory cytokine TNF. Thus, in addition to its accepted role in intrathymic selection events, TCR signaling can also play an important role in the regulation of thymic emigration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585545     DOI: 10.4049/jimmunol.176.8.4553

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.

Authors:  Raffi Gugasyan; Elisha Horat; Sarah A Kinkel; Fiona Ross; George Grigoriadis; Daniel Gray; Meredith O'Keeffe; Stuart P Berzins; Gabrielle T Belz; Raelene J Grumont; Ashish Banerjee; Andreas Strasser; Dale I Godfrey; Philip N Tsichlis; Steve Gerondakis
Journal:  EMBO J       Date:  2011-11-29       Impact factor: 11.598

2.  T-cell migration: Kruppeled T cells move again.

Authors:  Kristin A Hogquist; Michael A Weinreich; Stephen C Jameson
Journal:  Immunol Cell Biol       Date:  2008-04-01       Impact factor: 5.126

Review 3.  Signal integration and crosstalk during thymocyte migration and emigration.

Authors:  Paul E Love; Avinash Bhandoola
Journal:  Nat Rev Immunol       Date:  2011-06-24       Impact factor: 53.106

Review 4.  Tolerance has its limits: how the thymus copes with infection.

Authors:  Cláudio Nunes-Alves; Claudia Nobrega; Samuel M Behar; Margarida Correia-Neves
Journal:  Trends Immunol       Date:  2013-07-16       Impact factor: 16.687

Review 5.  Thymic emigration: when and how T cells leave home.

Authors:  Michael A Weinreich; Kristin A Hogquist
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

6.  Maturation-dependent licensing of naive T cells for rapid TNF production.

Authors:  Bhavana Priyadharshini; Raymond M Welsh; Dale L Greiner; Rachel M Gerstein; Michael A Brehm
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

7.  Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress.

Authors:  Jesus Zamora-Pineda; Ashok Kumar; Jung H Suh; Meng Zhang; Julie D Saba
Journal:  J Exp Med       Date:  2016-10-17       Impact factor: 14.307

8.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.